Reflux

6. Esophageal motor disorder with absent peristalsis and incomplete LES relaxation. (9)
7. Food becoming lodged in the esophagus; strongly associated with EoE. (9)
9. Acid-suppressing medication class without definite benefit for uncomplicated infant reflux (3)
10. Evaluation considered for concerning symptoms, persistent symptoms despite treatment, or suspected EoE. (9)
11. Medication class that inhibits the H2 receptor on the gastric parietal cell. (4)
13. Study that should NOT be ordered to diagnose reflux, but helps evaluate anatomic causes of vomiting. (3)
14. Chronic immune-mediated disorder of the esophagus with esophageal dysfunction and eosinophilia (3)
16. Inflammatory cell whose presence in esophageal tissue is central to the diagnosis of EoE. (10)
17. Another term used for passage of stomach contents back into the esophagus. (13)
18. Feeding intervention that can reduce regurgitation and vomiting episodes in infants. (10)
20. Transient lower esophageal sphincter relaxation; a key mechanism of infant reflux. (5)

1. Test component that detects intraluminal bolus movement and can identify acid and nonacid reflux. (9)
2. Swallowed topical corticosteroid used to treat EoE. (11)
3. Fundoplication procedure considered for selected life-threatening GERD complications. (6)
4. Rapid development of tolerance that can occur with H2 receptor antagonists. (13)
5. Syndrome associated with GERD featuring dystonic spasmodic head, neck, and back posturing. (8)
8. Difficulty swallowing; a common EoE symptom in older children and adolescents. (9)
12. Topical corticosteroid often mixed with sucralose for swallowed EoE treatment. (10)
15. Amino-acid-based diet/formula used as a treatment option for EoE. (9)
19. Reflux that causes troublesome symptoms or complications such as feeding difficulty or poor weight gain. (4)